Healthcare Facilities company Artemis Medicare Services announced Q2FY26 results Revenue from operations up by 13.8% at Rs 27,470 lakh, against Rs 24,142 lakh. EBITDA of Rs 5,827 lakh against Rs 4,970 lakh, at a margin of 21.2%. PAT of Rs 3,000 lakh up by 35.6%, against Rs 2,213 lakh. Onkar Kanwar, Chairman, Artemis Medicare Services, said: “We are pleased to report another quarter of steady progress, building on the strong momentum of FY26. In Q2, we continued to deliver healthy growth and robust operational performance, driven by disciplined execution, cost optimization, and a sustained focus on clinical and service excellence. Our profitability and margins remained resilient, supported by an improved case and payor mix, higher international patient volumes, and continued operational efficiency. ARPOB remained at elevated levels during the quarter, reaffirming our strong positioning in high-acuity care and Medical Value Travel. On the expansion front, the ramp-up of newly added beds at the flagship hospital’s third tower is progressing well and is expected to contribute meaningfully to growth in the coming quarters. The operationalization of our upcoming unit in Raipur is also on track and targeted for March 2026. As we look ahead, our priorities remain clear — driving sustainable growth through operational excellence, network expansion, and strategic partnerships, while continuing to strengthen Artemis’ position as one of India’s most trusted and forward-looking healthcare institutions.” Result PDF
Healthcare Facilities company Artemis Medicare Services announced Q1FY26 results Q1FY26 Consolidated Financial Highlights: Net Revenue from operations was up 14.2% to close at Rs 2,550 million, as against Rs 2,232 million in Q1FY25. EBITDA reported was Rs 483 million at a margin of 19.0%, as against Rs 406 million. Net profit for Q1 closed at Rs 212 million, as against Rs 165 million in the Q1FY25. Q1FY26 Standalone Financial Highlights: Average gross revenue per occupied bed (ARPOB) was at Rs 83,900, as against Rs 79,200. Net Revenue from operations was up 16.0% to close at Rs 2,412 million, as against Rs 2,080 million in Q1FY25. EBITDA reported was Rs 495 million at a margin of 20.5%, as against Rs 415 million. Bed capacity utilisation stood at 61.2%. Revenues from overseas patients increased by 31.4% to Rs 704 million from Rs 536 million. Overseas patients contributed 29% to Net Revenue. Average length of stay (ALOS) at 3.7 days compared to 3.6 days. Onkar Kanwar, Chairman, Artemis Medicare Services, said: “We are pleased to announce a strong start to FY26, with Q1 delivering consistent growth and resilient operational performance despite being a seasonally soft quarter. Our continued focus on cost optimization, operational efficiency, and disciplined execution has enabled us to maintain healthy profitability and margins. Our highest-ever ARPOB, driven by an optimized case and payer mix and strong international patient inflow, reinforces our position as a leader in Medical Value Travel. During the quarter, we added new beds at our flagship hospital’s third tower, strengthening capacity and improving unit economics in the coming quarters. We also signed a binding MoU with Dr. Vidya Sagar Kaushalya Devi Memorial Health Centre for a proposed Medical Services Agreement, marking an important step in expanding in North India. On the clinical front, we launched India’s first private Geriatrics & Longevity Department and partnered with KIMS, Hyderabad for heart-lung transplants, underscoring our commitment to advanced, patient-centric care. Looking ahead, we remain focused on sustainable growth through operational excellence, geographic expansion and strategic partnerships, as we continue building Artemis into one of India’s most trusted healthcare brands.” Result PDF
Healthcare Facilities company Artemis Medicare Services announced Q4FY25 & FY25 results Q4FY25 Financial Highlights: Net Revenue from operations was up 6.5% to close at Rs 2,399 million, as against Rs 2,252 million in Q4FY24 EBITDA reported was Rs 482 million at a margin of 20.1%, as against Rs 399 million Net profit for Q4 closed at Rs 229 million, as against Rs 143 million in the Q4FY24 FY25 Financial Highlights: Net Revenue from operations was up 6.6% to close at Rs 9,369 million, as against Rs 8,786 million in FY24 EBITDA reported was Rs 1,848 million at a margin of 19.7%, as against Rs 1,401 million Net profit for 12 Months closed at Rs 822 million, as against Rs 491 million in the same period last fiscal Commenting on the company’s performance, Onkar Kanwar, Chairman, Artemis Medicare Services said “Artemis concluded FY25 on a strong and positive trajectory, delivering consistent performance and steady growth across the year. We have continued to advance in both clinical excellence and operational capabilities, reaffirming our commitment to provide high-quality, accessible healthcare to the communities we serve. During the year we also inaugurated our third tower, which will be commissioned in a phase-wise manner to accommodate the increasing demand from our growing patient base. To fuel our next growth phase, we raised Rs 330 Crores from the International Finance Corporation (IFC), enabling strategic expansion across Delhi NCR and select Tier 2 cities through both brownfield and greenfield projects. The Board has approved a long-term Operations & Management and Medical Services Agreement for a 300+ bed super-speciality hospital in Raipur. This deal marks a key step in expanding our footprint in Central India and reinforces our mission to deliver advanced healthcare solutions across geographies. As we look ahead, our unwavering focus remains on creating long-term value for our patients, shareholders, and employees, while building Artemis into one of India’s most trusted and respected healthcare brands.” Result PDF
Healthcare Facilities company Artemis Medicare Services announced Q3FY25 results Net Revenue from Operations increased by 6.2% to Rs 2,324 million from Rs 2,188 million EBITDA increased by 34.4% to Rs 463 million from Rs 344 million EBITDA margin at 19.9% compared to 15.7% PBT increased by 64.4% to Rs 268 million from Rs 163 million with margin of 11.5% PAT increased by 78.3% to Rs 206 million from Rs 116 million, with margin of 8.9% Devlina Chakravarty, Managing Director of Artemis Medicare Services, commented: "The company has delivered a robust performance in Q3 FY25 and 9M FY25, driven by our unwavering focus on improving key business metrics and operational efficiencies. Despite this being a seasonally muted quarter, we have been able to achieve YoY growth and posted highest ever ARPOB by optimising the payer mix. Additionally, our increasing revenue contribution from international patients underscores our prominence as a preferred destination for Medical Value Travel. To cater to our growing customer base, we are focusing on ramping up the occupancy in the third tower. With this, we expect to further improve our performance by leveraging economies of scale and improving cost efficiencies. During the quarter, we have taken initiatives to enhance operational efficiencies by removing bottlenecks in the processes and improving patient experience. We have also announced advanced tech-driven physiotherapy services in a strategic tie-up with Abhinav Bindra Targeting Performance (ABTP), aiming to revolutionise patient care by offering tailor made services. Aligned with our strategic growth initiatives, we are streamlining our efforts to launch operations at our recently announced Raipur facility within the next year, marking our access into central India. Furthermore, we continue to explore expansion opportunities in the super-speciality segment, allowing us to strengthen our brand, expand our footprint, and achieve our growth plans." Result PDF
Healthcare Facilities company Artemis Medicare Services announced H1FY25 & Q2FY25 results Q2FY25 Financial Highlights: Net Revenue from Operations increased by 7.3% to Rs 2,414 million from Rs 2,250 million. EBITDA increased by 35.7% to Rs 497 million from Rs 366 million. EBITDA margin at 20.6% compared to 16.3%. PBT increased by 62.6% to Rs 306 million from Rs 188 million with margin of 12.7%. PAT increased by 63.5% to Rs 221 million from Rs 135 million, with margin of 9.2%. H1FY25 Financial Highlights: Net Revenue from Operations increased by 6.9% to Rs 4,646 million from Rs 4,345 million. EBITDA increased by 37.2% to Rs 903 million from Rs 658 million, with margin of 19.4% over 15.1%. PAT increased by 66.0% to Rs 387 million from Rs 233 million, with margin of 8.3% over 5.4%. Devlina Chakravarty, Managing Director of Artemis Medicare Services, said: "We are pleased to announce the strong performance of Q2FY25 and H1FY25, with our continuous focus on all key metrics. We have been able to achieve our best-ever performance with the highest revenue and EBITDA margins, by harnessing economies of scale and improving cost efficiencies. We have also inaugurated the third tower, which will be operationalised in a phase-wise manner to cater to the increasing customer base and further enhance our operational and financial performance. On the Operational front, we concentrated on refining the payer mix and removing bottlenecks, resulting in one of the industry-leading ARPOBs and improvement in margins. Our high revenue share from international patients underscores our role and recognition as a trusted centre for Medical Value Travel. In line with our strategic growth initiatives, the Board has approved to enter into a long term Operations & Management and Medical Services Agreement in Raipur for a 300+ bed super speciality hospital subject to completion of customary closing conditions. This hospital will be operational in approx. one year and will help us extend our reach to central India. We are further exploring more expansion opportunities in the super-speciality segment, enabling us to leverage our brand, strengthen our presence and lay a foundation for future growth." Result PDF
Healtcare Facilities company Artemis Medicare Services announced Q1FY25 results: Net Revenue from Operations increased by 6.5% to Rs 2,232 million from Rs 2,095 million EBITDA increased by 39% to Rs 406 million from Rs 292 million EBITDA margin at 18.2% compared to 13.9% at the consolidated level Consolidated PBT increased by 65.1% to Rs 216 million from Rs 131 million with margin of 9.7% Consolidated PAT increased by 69.5% to Rs 165 million from Rs 98 million, with margin of 7.4% Announcing the results, Devlina Chakravarty, Managing Director of Artemis Medicare Services, commented: "Our robust performance of Q1FY25 reflects our conscious efforts towards streamlining all the financial and operational metrics. This is one of our best-ever quarterly performance with our highest ever ARPOB and EBITDA, giving a promising start to the year despite it being a seasonally muted quarter. We have focussed on leveraging cost efficiencies and optimising asset utilisation, which is reflected in our highest EBITDA margins. During the quarter, we have brought our third tower to the final stages and we look forward to operationalising it soon, which will further enhance our unit economics and overall financial and operational metrics. Additionally, our asset-light centres have shown improved performance as a result of our concentrated efforts. This quarter also marked our successful fund raise of Rs 3,300 million from International Finance Corporation (IFC), a member of the World Bank Group to accelerate our growth plans. We plan to expand our presence in the superspeciality segment through addition of larger sized hospitals in our group. With this capacity enhancement we want to extend our top-of-the-line clinical expertise, patient care and operating efficiencies to serve a larger patient base and help solve complex health issues in the larger interest of society in a cost effective manner." Result PDF
Healthcare Facilities company Artemis Medicare Services announced consolidated Q4FY24 & FY24 results: Q4FY24 Financial Highlights: Net Revenue from Operations increased by 15.3% to Rs 2,252 million from Rs 1,953 million EBITDA increased by 42.1% to Rs 399 million from Rs 280 million EBITDA margin at 17.7% compared to 14.4% PAT increased by 33.6% to Rs 143 million from Rs 107 million, with margin of 6.4% Net Debt of Rs 1,922 million as on 31st March 2024 Net Debt/Shareholder’s Equity of 0.42x FY24 Financial Highlights: Net Revenue from Operations of Rs 8,786 million compared to Rs 7,374 million, growth of 19.1% EBITDA increased by 38.3% to Rs 1,401 million from Rs 1,013 million EBITDA margin at 15.9% compared to 13.7% PAT increased by 29.3% to Rs 491 million from Rs 380 million, with margin of 5.6% Announcing the results, Dr. Devlina Chakravarty, Managing Director of Artemis Medicare Services, commented: "We are delighted to announce the strong performance of Q4FY24 and FY24, with growth across all major metrics. During the year, we fully operationalised the remaining beds in the second tower, helping us derive the benefits of economies of scale and improving our efficiencies. The construction of our third tower is also in the final stages, which, when operationalised, will enhance our financial and operational metrics. Additionally, as our asset light centres achieve maturity in the coming years, our consolidated performance will also improve. This year, we added a new centre under the Artemis Lite brand in Gurugram, catering to the New Gurugram area. The year also marked our presence overseas through the inauguration of the first hospital in Mauritius under Operations and Management agreement. Operationally, we focused on refining the case mix and payer mix and improving financial parameters, resulting in one of the highest-ever ARPOBs in the industry. Our industry leading revenue share from international patients asserts our role and recognition as a trusted centre for Medical Value Travel. We have also extended our OPD timings in the evening to serve more salaried-class patients. As part of our strategic growth initiatives, we are exploring expansion opportunities, which will help us leverage our brand, strengthen our presence in Northern India and act as a stepping stone to grow Artemis' presence in the region. Looking ahead into FY25, we are confident to continue our robust performance and become one of the most well-regarded healthcare provider in India. We will continue to focus on clinical and non-clinical excellence, with innovative strategies and plans to expand our footprint, domestically and internationally." Result PDF